Literature DB >> 8056727

Clozapine in the treatment of a young adolescent with schizophrenia.

L K Jacobsen1, M C Walker, J E Edwards, P B Chappell, J L Woolston.   

Abstract

Although recent reports have suggested that clozapine may be efficacious in the treatment of adolescents with schizophrenia, few studies have examined the use of clozapine in patients younger than 17 years of age. We describe highly successful trials of clozapine conducted in a 13-year-old girl and her cousin, both of whom developed severe symptoms of schizophrenia, which were refractory to neuroleptic medication, at the ages of 11 and 13 years, respectively. The pharmacology of and clinical experience with clozapine are reviewed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8056727     DOI: 10.1097/00004583-199406000-00004

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  4 in total

Review 1.  Tolerability profile of atypical antipsychotics in children and adolescents.

Authors:  K A Stigler; M N Potenza; C J McDougle
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.

Authors:  Paz Toren; Sharon Ratner; Nathaniel Laor; Abraham Weizman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 3.  Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.

Authors:  Kimberly A Stigler; Marc N Potenza; David J Posey; Christopher J McDougle
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 4.  Management of schizophrenia in children and adolescents. The role of clozapine.

Authors:  H Remschmidt; C Fleischhaker; K Hennighausen; E Schulz
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.930

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.